Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Modified-Release Drug Delivery Systems: Stimuli-Activated01:30

Modified-Release Drug Delivery Systems: Stimuli-Activated

Stimuli-activated drug delivery systems are designed to release drugs in response to specific physical, chemical, or biological stimuli. These systems often utilize hydrogels—three-dimensional, hydrophilic polymer networks capable of swelling in aqueous environments and retaining significant fluid volumes. Upon exposure to particular stimuli, these hydrogels undergo structural transitions that allow the embedded drug to be released. Due to this adaptive behavior, such systems are also called...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Identification of drug candidates against glioblastoma with machine learning and high-throughput screening of heterogeneous cellular models.

Digital discovery·2026
Same author

Discovery of a Highly Potent and Selective mTOR Inhibitor that Strongly Suppresses Glioblastoma Multiforme Cell Growth.

Journal of medicinal chemistry·2026
Same author

Near-Infrared Light-Accelerated Bioorthogonal Drug Uncaging and Photothermal Ablation by Anisotropic Pd@Au Plasmonic Nanorods.

Journal of the American Chemical Society·2025
Same author

Dendritic Platinum Nanoparticles Shielded by Pt-S PEGylation as Intracellular Reactors for Bioorthogonal Uncaging Chemistry.

Angewandte Chemie (International ed. in English)·2025
Same author

Ligand-centred phenotype-driven development of potent kinase inhibitors against oesophageal cancer.

RSC medicinal chemistry·2024
Same author

Tuning singlet oxygen generation with caged organic photosensitizers.

Nature communications·2024

Related Experiment Video

Updated: Jun 18, 2026

Chemoselective Modification of Viral Surfaces via Bioorthogonal Click Chemistry
12:31

Chemoselective Modification of Viral Surfaces via Bioorthogonal Click Chemistry

Published on: August 19, 2012

24.4K

Development of Biocompatible Cu(I)-Microdevices for Bioorthogonal Uncaging and Click Reactions.

Melissa van de L'Isle1, Stephen Croke1, Teresa Valero1,2,3,4

  • 1Edinburgh Cancer Research, Institute of Genetics & Cancer, University of Edinburgh, Crewe Road South, Edinburgh, EH4 2XR, UK.

Chemistry (Weinheim an Der Bergstrasse, Germany)
|March 21, 2024
PubMed
Summary

Researchers developed solid-supported copper(I) microdevices for bioorthogonal reactions, enabling controlled drug release and synthesis of targeted therapeutics like PROTACs in living systems.

More Related Videos

An Optimized Protocol for the Efficient Radiolabeling of Gold Nanoparticles by Using a 125I-labeled Azide Prosthetic Group
07:23

An Optimized Protocol for the Efficient Radiolabeling of Gold Nanoparticles by Using a 125I-labeled Azide Prosthetic Group

Published on: October 10, 2016

8.2K
Design, Synthesis, and Photochemical Properties of Clickable Caged Compounds
09:44

Design, Synthesis, and Photochemical Properties of Clickable Caged Compounds

Published on: October 15, 2019

12.2K

Related Experiment Videos

Last Updated: Jun 18, 2026

Chemoselective Modification of Viral Surfaces via Bioorthogonal Click Chemistry
12:31

Chemoselective Modification of Viral Surfaces via Bioorthogonal Click Chemistry

Published on: August 19, 2012

24.4K
An Optimized Protocol for the Efficient Radiolabeling of Gold Nanoparticles by Using a 125I-labeled Azide Prosthetic Group
07:23

An Optimized Protocol for the Efficient Radiolabeling of Gold Nanoparticles by Using a 125I-labeled Azide Prosthetic Group

Published on: October 10, 2016

8.2K
Design, Synthesis, and Photochemical Properties of Clickable Caged Compounds
09:44

Design, Synthesis, and Photochemical Properties of Clickable Caged Compounds

Published on: October 15, 2019

12.2K

Area of Science:

  • Bioorthogonal chemistry
  • Catalysis
  • Drug delivery

Background:

  • Transition-metal-catalyzed bioorthogonal reactions offer spatiotemporal control for enzymatic functions and drug delivery.
  • Improving drug tolerability and pharmacokinetic properties is a key goal in experimental therapeutics.
  • Preclinical studies have shown the potential of bioorthogonal catalysis for in situ drug generation.

Purpose of the Study:

  • To develop solid-supported copper(I) microdevices for bioorthogonal applications.
  • To investigate their use in uncaging reactions and click chemistry.
  • To explore their utility in synthesizing Proteolysis Targeting Chimeras (PROTACs).

Main Methods:

  • Preparation of ligand-functionalized polymeric devices.
  • Development of copper(I)-sensitive sensors.
  • Testing under biologically compatible conditions.
  • CuAAC (Copper-catalyzed Azide-Alkyne Cycloaddition) assembly for PROTAC synthesis.

Main Results:

  • Successful development of solid-supported Cu(I)-microdevices.
  • Demonstration of bioorthogonal uncaging and click reactions.
  • Creation of Cu(I)-sensitive sensors with on-off capabilities.
  • Preliminary synthesis of PROTACs using the developed microdevices.

Conclusions:

  • Solid-supported Cu(I)-microdevices are effective tools for bioorthogonal chemistry.
  • These devices show promise for in situ drug synthesis and targeted therapeutic development.
  • The methodology facilitates the modular assembly of complex molecules like PROTACs.